Drug from bilgen called aldhem am looked to show some promise or its extremely controversial drug. A bunch of doctors on the fda advisory committee were concerned that it really wasn't that effective, and that didn't really slow the progression of alshimers. And so when the fda approved this drug last summer, a bunch of the advisers resigned.